TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 234 filers reported holding TG THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $241,000 | -7.3% | 5,000 | 0.0% | 0.02% | -13.8% |
| Q4 2020 | $260,000 | +33.3% | 5,000 | -50.0% | 0.03% | +7.4% |
| Q2 2020 | $195,000 | +99.0% | 10,000 | 0.0% | 0.03% | +92.9% |
| Q1 2020 | $98,000 | -65.1% | 10,000 | -80.0% | 0.01% | -53.3% |
| Q3 2019 | $281,000 | -35.1% | 50,000 | 0.0% | 0.03% | -36.2% |
| Q2 2019 | $433,000 | +7.7% | 50,000 | 0.0% | 0.05% | +11.9% |
| Q1 2019 | $402,000 | +96.1% | 50,000 | 0.0% | 0.04% | +82.6% |
| Q4 2018 | $205,000 | -77.1% | 50,000 | -68.8% | 0.02% | -74.7% |
| Q3 2018 | $896,000 | -57.4% | 160,000 | 0.0% | 0.09% | -60.8% |
| Q2 2018 | $2,104,000 | -7.4% | 160,000 | 0.0% | 0.23% | -13.1% |
| Q1 2018 | $2,272,000 | +73.2% | 160,000 | 0.0% | 0.27% | +72.3% |
| Q4 2017 | $1,312,000 | -30.8% | 160,000 | 0.0% | 0.16% | -36.7% |
| Q3 2017 | $1,896,000 | +214.4% | 160,000 | +166.7% | 0.24% | +202.5% |
| Q2 2017 | $603,000 | -13.7% | 60,000 | 0.0% | 0.08% | -18.2% |
| Q1 2017 | $699,000 | – | 60,000 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,890,000 | $15,800,400 | 5.14% |
| Ghost Tree Capital, LLC | 1,000,000 | $8,360,000 | 2.75% |
| Soleus Capital Management, L.P. | 2,884,382 | $24,113,434 | 2.22% |
| M28 Capital Management LP | 216,600 | $1,810,776 | 2.08% |
| Paradigm Biocapital Advisors LP | 3,619,015 | $30,254,965 | 2.05% |
| 683 Capital Management, LLC | 1,350,000 | $11,286,000 | 0.88% |
| Parkwood LLC | 165,414 | $6,081 | 0.66% |
| Spotlight Asset Group, Inc. | 79,000 | $660,440 | 0.60% |
| Pier Capital, LLC | 392,709 | $3,283,047 | 0.53% |
| Quantum Private Wealth, LLC | 91,081 | $761,438 | 0.36% |